Short Interest in Fortress Biotech, Inc. (NASDAQ:FBIOP) Grows By ∞

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 840 shares, an increase of ∞ from the July 15th total of 0 shares. Based on an average trading volume of 8,927 shares, the days-to-cover ratio is currently 0.1 days.

Fortress Biotech Stock Performance

Shares of NASDAQ FBIOP traded down $0.45 during midday trading on Friday, hitting $18.66. The company’s stock had a trading volume of 40,432 shares, compared to its average volume of 21,796. The stock has a fifty day moving average price of $19.52 and a 200 day moving average price of $15.96. Fortress Biotech has a one year low of $6.27 and a one year high of $21.43.

Fortress Biotech Company Profile

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.